Siga Technologies (SIGA) Free Cash Flow Growth (1y) (2011 - 2025)
Siga Technologies (SIGA) Free Cash Flow Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 134.35% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 17.21% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -37.45% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 58.76% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 97.24% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 43.69% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 35.56% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Siga Technologies | 213.38 Mn | 58.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -36.43% |
| Jun 30, 2025 | 960.03% |
| Mar 31, 2025 | 215.02% |
| Dec 31, 2024 | -28.77% |
| Sep 30, 2024 | -45.23% |
| Jun 30, 2024 | 265.23% |
| Mar 31, 2024 | -125.03% |
| Dec 31, 2023 | 1,074.95% |
| Sep 30, 2023 | -6.65% |
| Jun 30, 2023 | -63.14% |
| Mar 31, 2023 | -56.89% |
| Dec 31, 2022 | -150.42% |
| Sep 30, 2022 | -393.58% |
| Jun 30, 2022 | -53.21% |
| Mar 31, 2022 | 1,276.47% |
| Dec 31, 2021 | -65.01% |
| Sep 30, 2021 | -94.80% |
| Jun 30, 2021 | 84.15% |
| Mar 31, 2021 | -245.75% |
| Dec 31, 2020 | 422.11% |